Skip to main content
Top
Published in: BMC Pediatrics 1/2019

Open Access 01-12-2019 | Hypercholesterolemia | Research article

Selective screening for familial hypercholesterolemia in Austrian children - first year results

Authors: Alexandra Kreissl, Nina Walleczek, Pinky Rose Espina, Ulrike Hallwirth, Susanne Greber-Platzer

Published in: BMC Pediatrics | Issue 1/2019

Login to get access

Abstract

Background

Familial hypercholesterolemia (FH), the most frequent monogenetic hereditary disorder, is underdiagnosed and undertreated. Early identification of FH is essential because of the increased risk for premature cardiovascular diseases and childhood might be the optimal period for cholesterol screening. Aim of this selective screening was to detect familial hypercholesterolemia, the most frequent monogenetic hereditary disorder in children to guarantee early detection and treatment. The Austrian strategy for primary schools, to perform a pre-school examination by school physicians, allows to reach all children aged 5–7 years.

Methods

The screening was conducted within the school enrolment examinations in all 215 public primary schools in Vienna between January to May 2017. Positive cholesterol screening was defined by non-HDL-C > 160 mg/dL and/or LDL-C > 130 mg/dL.

Results

In total, 18,152 children had their school enrolment examination. From 133 tested pre-school children, nine individuals were positive-screened with a mean LDL-C of 161 ± 26 mg/dL, non-HDL-C of 181 ± 24 mg/dL and total cholesterol (TC) of 239 ± 23 mg/dL. From 85 siblings, four individuals were positively screened with a mean LDL-C of 150 ± 7 mg/dL, non-HDL-C of 184 ± 8 mg/dL and TC of 231 ± 10 mg/dL. Patients did not have any xanthomas, xanthelasms, arcus lipoides, or any cardiovascular comorbidities.

Conclusions

Screening at early childhood by school physicians seems to be a successful strategy and possible. With this Austrian selective screening method, FH Kids Austria, we could find nine patients with positive raised level LDL-cholesterol and/or non-HDL cholesterol out of 133 blood tests. Prevention of cardiovascular diseases is essential and it is our duty to increase the awareness of this disease. Limitations of the FH Kids project were reduced participation of school physicians and refusal of the parents.
Literature
1.
go back to reference Wiegman A, Gidding SS, Watts GF, Chapman MJ, Ginsberg HN, Cuchel M, et al. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. Eur Heart J. 2015;36:2425–37.CrossRef Wiegman A, Gidding SS, Watts GF, Chapman MJ, Ginsberg HN, Cuchel M, et al. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. Eur Heart J. 2015;36:2425–37.CrossRef
2.
go back to reference Kusters DM, Hutten BA, McCrindle BW, Cassiman D, Francis GA, Gagne C, et al. Design and baseline data of a pediatric study with rosuvastatin in familial hypercholesterolemia. J Clin Lipidol. 2013;7:408–13.CrossRef Kusters DM, Hutten BA, McCrindle BW, Cassiman D, Francis GA, Gagne C, et al. Design and baseline data of a pediatric study with rosuvastatin in familial hypercholesterolemia. J Clin Lipidol. 2013;7:408–13.CrossRef
3.
go back to reference Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986;232:34–47.CrossRef Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986;232:34–47.CrossRef
4.
go back to reference Ose L. Familial hypercholesterolemia from children to adults. Cardiovasc Drugs Ther. 2002;16:289–93.CrossRef Ose L. Familial hypercholesterolemia from children to adults. Cardiovasc Drugs Ther. 2002;16:289–93.CrossRef
5.
go back to reference Sjouke B, Kusters DM, Kindt I, Besseling J, Defesche JC, Sijbrands EJ, et al. Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome. Eur Heart J. 2015;36:560–5.CrossRef Sjouke B, Kusters DM, Kindt I, Besseling J, Defesche JC, Sijbrands EJ, et al. Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome. Eur Heart J. 2015;36:560–5.CrossRef
6.
go back to reference Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European atherosclerosis society. Eur Heart J. 2013;34:3478–90.CrossRef Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European atherosclerosis society. Eur Heart J. 2013;34:3478–90.CrossRef
7.
go back to reference Watts GF, Gidding S, Wierzbicki AS, Toth PP, Alonso R, Brown WV, et al. Integrated guidance on the care of familial hypercholesterolaemia from the international FH Foundation. Eur J Prev Cardiol. 2015;22:849–54.CrossRef Watts GF, Gidding S, Wierzbicki AS, Toth PP, Alonso R, Brown WV, et al. Integrated guidance on the care of familial hypercholesterolaemia from the international FH Foundation. Eur J Prev Cardiol. 2015;22:849–54.CrossRef
8.
go back to reference Cuchel M, Bruckert E, Ginsberg HN, Raal FJ, Santos RD, Hegele RA, et al. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the consensus panel on familial Hypercholesterolaemia of the European atherosclerosis society. Eur Heart J. 2014;35:2146–57.CrossRef Cuchel M, Bruckert E, Ginsberg HN, Raal FJ, Santos RD, Hegele RA, et al. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the consensus panel on familial Hypercholesterolaemia of the European atherosclerosis society. Eur Heart J. 2014;35:2146–57.CrossRef
9.
go back to reference Kavey RE, Daniels SR, Lauer RM, Atkins DL, Hayman LL, Taubert K. American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation. 2003;107:1562–6.CrossRef Kavey RE, Daniels SR, Lauer RM, Atkins DL, Hayman LL, Taubert K. American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation. 2003;107:1562–6.CrossRef
10.
go back to reference Haney EM, Huffman LH, Bougatsos C, Freeman M, Steiner RD, Nelson HD. Screening and treatment for lipid disorders in children and adolescents: systematic evidence review for the US preventive services task Force. Pediatrics. 2007;120:189–214.CrossRef Haney EM, Huffman LH, Bougatsos C, Freeman M, Steiner RD, Nelson HD. Screening and treatment for lipid disorders in children and adolescents: systematic evidence review for the US preventive services task Force. Pediatrics. 2007;120:189–214.CrossRef
11.
go back to reference American Academy of Pediatrics. National Cholesterol Education Program: report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics. 1992;89(3 Pt 2):525–84. American Academy of Pediatrics. National Cholesterol Education Program: report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics. 1992;89(3 Pt 2):525–84.
12.
go back to reference Langslet G, Ose L. Screening methods in the diagnosis and assessment of children and adolescents with familial hypercholesterolemia. Expert Rev Cardiovasc Ther. 2013;11:1061–6.CrossRef Langslet G, Ose L. Screening methods in the diagnosis and assessment of children and adolescents with familial hypercholesterolemia. Expert Rev Cardiovasc Ther. 2013;11:1061–6.CrossRef
13.
go back to reference Galema-Boers JM, Versmissen J, Roeters van Lennep HW, Dusault-Wijkstra JE, Williams M, Roeters van Lennep JE. Cascade screening of familial hypercholesterolemia must go on. Atherosclerosis. 2015;242:415–7.CrossRef Galema-Boers JM, Versmissen J, Roeters van Lennep HW, Dusault-Wijkstra JE, Williams M, Roeters van Lennep JE. Cascade screening of familial hypercholesterolemia must go on. Atherosclerosis. 2015;242:415–7.CrossRef
14.
go back to reference Plana N, Rodriguez-Borjabad C, Ibarretxe D, Masana L. Familial hypercholesterolemia in childhood and adolescents: a hidden reality. Clin Investig Arterioscler. 2017;29:129–40.PubMed Plana N, Rodriguez-Borjabad C, Ibarretxe D, Masana L. Familial hypercholesterolemia in childhood and adolescents: a hidden reality. Clin Investig Arterioscler. 2017;29:129–40.PubMed
15.
go back to reference Ritchie SK, Murphy EC, Ice C, Cottrell LA, Minor V, Elliott E, et al. Universal versus targeted blood cholesterol screening among youth: the CARDIAC project. Pediatrics. 2010;126:260–5.CrossRef Ritchie SK, Murphy EC, Ice C, Cottrell LA, Minor V, Elliott E, et al. Universal versus targeted blood cholesterol screening among youth: the CARDIAC project. Pediatrics. 2010;126:260–5.CrossRef
16.
go back to reference Eissa MA, Wen E, Mihalopoulos NL, Grunbaum JA, Labarthe DR. Evaluation of AAP guidelines for cholesterol screening in youth: project HeartBeat! Am J Prev Med. 2009;37(Suppl 1):71–7.CrossRef Eissa MA, Wen E, Mihalopoulos NL, Grunbaum JA, Labarthe DR. Evaluation of AAP guidelines for cholesterol screening in youth: project HeartBeat! Am J Prev Med. 2009;37(Suppl 1):71–7.CrossRef
17.
go back to reference Expert Panel on. Integrated guidelines for cardiovascular H, risk reduction in C, adolescents, National Heart L, blood I. expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128(Suppl 5):213–56. Expert Panel on. Integrated guidelines for cardiovascular H, risk reduction in C, adolescents, National Heart L, blood I. expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128(Suppl 5):213–56.
18.
go back to reference Wald DS, Bestwick JP, Morris JK, Whyte K, Jenkins L, Wald NJ. Child-parent familial hypercholesterolemia screening in primary care. N Engl J Med. 2016;375:1628–37.CrossRef Wald DS, Bestwick JP, Morris JK, Whyte K, Jenkins L, Wald NJ. Child-parent familial hypercholesterolemia screening in primary care. N Engl J Med. 2016;375:1628–37.CrossRef
19.
go back to reference Klancar G, Groselj U, Kovac J, Bratanic N, Bratina N, Trebusak Podkrajsek K, et al. Universal screening for familial hypercholesterolemia in children. J Am Coll Cardiol. 2015;66:1250–7.CrossRef Klancar G, Groselj U, Kovac J, Bratanic N, Bratina N, Trebusak Podkrajsek K, et al. Universal screening for familial hypercholesterolemia in children. J Am Coll Cardiol. 2015;66:1250–7.CrossRef
20.
go back to reference Fábryová L, Hlavatá A, Cižmárová E, Šimurka P, Debreová M, Dukát A, et al. Recommendations for diagnosis and treatment of dyslipidaemia in children and adolescents. Pediatr prax. 2011;12(Suppl 1):3–9. Fábryová L, Hlavatá A, Cižmárová E, Šimurka P, Debreová M, Dukát A, et al. Recommendations for diagnosis and treatment of dyslipidaemia in children and adolescents. Pediatr prax. 2011;12(Suppl 1):3–9.
21.
go back to reference Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC/EAS guidelines for the Management of Dyslipidaemias. Eur Heart J. 2016;37:2999–3058.CrossRef Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC/EAS guidelines for the Management of Dyslipidaemias. Eur Heart J. 2016;37:2999–3058.CrossRef
22.
go back to reference Daniels SR, Gidding SS, de Ferranti SD. National Lipid Association Expert Panel on familial H. pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on familial hypercholesterolemia. J Clin Lipidol. 2011;5(Suppl 3):30–7.CrossRef Daniels SR, Gidding SS, de Ferranti SD. National Lipid Association Expert Panel on familial H. pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on familial hypercholesterolemia. J Clin Lipidol. 2011;5(Suppl 3):30–7.CrossRef
23.
go back to reference Descamps OS, Tenoutasse S, Stephenne X, Gies I, Beauloye V, Lebrethon MC, et al. Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization. Atherosclerosis. 2011;218:272–80.CrossRef Descamps OS, Tenoutasse S, Stephenne X, Gies I, Beauloye V, Lebrethon MC, et al. Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization. Atherosclerosis. 2011;218:272–80.CrossRef
24.
go back to reference Force USPST, Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, et al. Screening for lipid disorders in children and adolescents: US preventive services task Force recommendation statement. Jama. 2016;316:625–33.CrossRef Force USPST, Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, et al. Screening for lipid disorders in children and adolescents: US preventive services task Force recommendation statement. Jama. 2016;316:625–33.CrossRef
25.
go back to reference Urbina EM, de Ferranti SD. Lipid screening in children and adolescents. Jama. 2016;316:589–91.CrossRef Urbina EM, de Ferranti SD. Lipid screening in children and adolescents. Jama. 2016;316:589–91.CrossRef
26.
go back to reference Kusters DM, de Beaufort C, Widhalm K, Guardamagna O, Bratina N, Ose L, et al. Paediatric screening for hypercholesterolaemia in Europe. Arch Dis Child. 2012;97:272–6.CrossRef Kusters DM, de Beaufort C, Widhalm K, Guardamagna O, Bratina N, Ose L, et al. Paediatric screening for hypercholesterolaemia in Europe. Arch Dis Child. 2012;97:272–6.CrossRef
27.
go back to reference Civeira F. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis. 2004;173:55–68.CrossRef Civeira F. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis. 2004;173:55–68.CrossRef
Metadata
Title
Selective screening for familial hypercholesterolemia in Austrian children - first year results
Authors
Alexandra Kreissl
Nina Walleczek
Pinky Rose Espina
Ulrike Hallwirth
Susanne Greber-Platzer
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2019
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-019-1586-4

Other articles of this Issue 1/2019

BMC Pediatrics 1/2019 Go to the issue